Wang Zeshen, Sun Pengcheng, Ju Yuming, Jin Shiyang, Wang Qiancheng, Wei Yuzhe, Zhu Guanyu, Wang Kuan
Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, 150, Haping Road, Nangang District, Harbin, 150076, Heilongjiang, China.
Updates Surg. 2025 Jan 20. doi: 10.1007/s13304-025-02108-1.
This study aimed to explore the safety, feasibility, and efficacy of using KangDuo-Surgical Robot-01 (KD-SR-01) for distal gastrectomy in patients with gastric cancer. We prospectively enrolled patients undergoing KD-SR-01 assisted distal gastrectomy at our center from September 2023 to December 2023. Data on baseline characteristics, perioperative details, and short-term follow-up were collected prospectively. Descriptive statistical analysis was performed. This study included 15 patients with a median age of 60 years (range: 44-74) and a median body mass index of 24.7 [interquartile range (IQR): 19.8-27.0]. None of the patients required conversion to laparotomy or open surgery during lymphadenectomy. Ten patients underwent D2+ lymphadenectomy, four had D2, and one had D1+. Eleven patients had robotic-assisted BII anastomosis, one had robotic-assisted BI anastomosis, and three had laparoscopic BII anastomosis. All patients had negative surgical margins. The median operative time was 210.0 min (IQR: 200.0-225.0), with a median anastomosis time of 32.0 min (IQR: 21.5-54.5) for robotic-assisted BII anastomosis and 20 min for BI anastomosis. The median estimated blood loss was 30 ml (range: 30-50), and the median postoperative hospital stay was 7.0 days (IQR: 7.0-8.0). Four patients (26.7%) experienced Clavien-Dindo grade II postoperative complications, including two cases of hypoalbuminemia, one case of pneumonia, and one case of moderate anemia, with no device-related complications. Short-term follow-up indicated normal postoperative recovery with no radiographic evidence of recurrence. The KD-SR-01 is safe, feasible, and effective for distal gastrectomy and robotic-assisted gastrointestinal reconstruction.
本研究旨在探讨使用康多手术机器人01（KD-SR-01）对胃癌患者进行远端胃切除术的安全性、可行性和有效性。我们前瞻性地纳入了2023年9月至2023年12月在本中心接受KD-SR-01辅助远端胃切除术的患者。前瞻性收集了患者的基线特征、围手术期细节和短期随访数据，并进行描述性统计分析。本研究共纳入15例患者，中位年龄为60岁（范围：44-74岁），中位体重指数为24.7[四分位数间距（IQR）：19.8-27.0]。所有患者在淋巴结清扫过程中均无需转为开腹手术或开放手术。10例患者接受了D2+淋巴结清扫，4例接受了D2清扫，1例接受了D1+清扫。11例患者接受了机器人辅助的毕II式吻合术，1例接受了机器人辅助的毕I式吻合术，3例接受了腹腔镜毕II式吻合术。所有患者手术切缘均为阴性。中位手术时间为210.0分钟（IQR：200.0-225.0），机器人辅助毕II式吻合术的中位吻合时间为32.0分钟（IQR：21.5-54.5），毕I式吻合术为20分钟。中位估计失血量为30毫升（范围：30-50），中位术后住院时间为7.0天（IQR：7.0-8.0）。4例患者（26.7%）发生Clavien-Dindo II级术后并发症，包括2例低蛋白血症、1例肺炎和1例中度贫血，无与器械相关的并发症。短期随访表明术后恢复正常，影像学检查无复发迹象。KD-SR-01用于远端胃切除术及机器人辅助胃肠道重建是安全、可行且有效的。
